◆ NeutralNVO
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GlobeNewswire Inc.·
Novo Nordisk announced that board members and executives received 74 shares each on August 5, 2026, through the company's Restricted Shares programme for the 100th Anniversary. The company also won a Dutch court injunction protecting patients from unapproved compounded semaglutide nasal spray, reinforcing patient safety and intellectual property rights. Additionally, Novo Nordisk reported adjusted operating profit of DKK 33,389 million for Q2 2026 and raised its full-year outlook.
Read Full Article at GlobeNewswire Inc. →